Napo Pharmaceuticals Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
21
- Latest Deal Type
-
M&A
Napo Pharmaceuticals General Information
Description
Developer of proprietary pharmaceuticals intended to offer medicines to high-margin Western markets. The company offers an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy, thereby enabling consumers to avoid the risk of potential worsening of disease due to delay of appropriate therapy.
Contact Information
Website
www.napopharma.com(Operating Subsidiary)
Corporate Office
- 200 Pine Street
- Suite 400
- San Francisco, CA 94104
- United States
Corporate Office
- 200 Pine Street
- Suite 400
- San Francisco, CA 94104
- United States
Napo Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 31-Jul-2017 | Completed | Generating Revenue | |||
| 15. Convertible Debt | 03-Jan-2017 | Completed | Generating Revenue | |||
| 14. Convertible Debt | 03-Jun-2014 | Completed | Generating Revenue | |||
| 13. Later Stage VC | 25-Oct-2011 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 26-Apr-2011 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 26-Oct-2010 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 09-Jul-2009 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 29-Dec-2008 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 23-Oct-2008 | $7.93M | $48.6M | Completed | Generating Revenue | |
| 7. PIPE | 17-Dec-2007 | $1.3M | $40.7M | Completed | Generating Revenue |
Napo Pharmaceuticals Comparisons
Industry
Financing
Details
Napo Pharmaceuticals Competitors (54)
One of Napo Pharmaceuticals’s 54 competitors is LEO Pharma, a Private Equity-Backed company based in Ballerup, Denmark.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LEO Pharma | Private Equity-Backed | Ballerup, Denmark | ||||
| Ardelyx | Formerly VC-backed | Waltham, MA | ||||
| Evoke Pharma | Formerly VC-backed | Solana Beach, CA | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Supernus | Formerly VC-backed | Rockville, MD |
Napo Pharmaceuticals Patents
Napo Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023355021-A1 | Lyophilized formulation of crofelemer and methods of treatment using the same | Pending | 28-Sep-2022 | ||
| EP-4593816-A2 | Lyophilized formulation of crofelemer and methods of treatment using the same | Pending | 28-Sep-2022 | ||
| EP-4593816-A4 | Lyophilized formulation of crofelemer and methods of treatment using the same | Pending | 28-Sep-2022 | ||
| US-20260102351-A1 | Lyophilized formulation of crofelemer and methods of treatment using the same | Pending | 28-Sep-2022 | ||
| WO-2024073007-A2 | Lyophilized formulation of crofelemer and methods of treatment using the same | Inactive | 28-Sep-2022 | A61K9/19 |
Napo Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Napo Pharmaceuticals Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Asian Pharma Investment | PE/Buyout | Minority | ||
| Asset Management Ventures | Venture Capital | Minority | ||
| Atlas Accelerator | Venture Capital | Minority | ||
| BVCF | Venture Capital | Minority | ||
| Bochnowski FamilyTrust | Family Office | Minority |
Napo Pharmaceuticals Investments (2)
Napo Pharmaceuticals’s most recent deal was a PIPE with Jaguar Health for . The deal was made on 03-Feb-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jaguar Health | 03-Feb-2016 | PIPE | Pharmaceuticals | ||
| Jaguar Health | 02-Apr-2015 | Early Stage VC | Pharmaceuticals |
Napo Pharmaceuticals FAQs
-
When was Napo Pharmaceuticals founded?
Napo Pharmaceuticals was founded in 2001.
-
Where is Napo Pharmaceuticals headquartered?
Napo Pharmaceuticals is headquartered in San Francisco, CA.
-
What is the size of Napo Pharmaceuticals?
Napo Pharmaceuticals has 21 total employees.
-
What industry is Napo Pharmaceuticals in?
Napo Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Napo Pharmaceuticals a private or public company?
Napo Pharmaceuticals is a Private company.
-
What is Napo Pharmaceuticals’s current revenue?
The current revenue for Napo Pharmaceuticals is .
-
How much funding has Napo Pharmaceuticals raised over time?
Napo Pharmaceuticals has raised $62.4M.
-
Who are Napo Pharmaceuticals’s investors?
Asian Pharma Investment, Asset Management Ventures, Atlas Accelerator, BVCF, and Bochnowski FamilyTrust are 5 of 13 investors who have invested in Napo Pharmaceuticals.
-
Who are Napo Pharmaceuticals’s competitors?
LEO Pharma, Ardelyx, Evoke Pharma, Pfizer (Vienna), and Supernus are some of the 54 competitors of Napo Pharmaceuticals.
-
When was Napo Pharmaceuticals acquired?
Napo Pharmaceuticals was acquired on 31-Jul-2017.
-
Who acquired Napo Pharmaceuticals?
Napo Pharmaceuticals was acquired by Jaguar Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
